Sangamo Therapeutics, Inc (SGMO): 10-Q filed May 14, 2026

Form type

10-Q

Filing date

May 14, 2026

Accession number

0001628280-26-035067

Filer

Sangamo Therapeutics, Inc (CIK 1001233)